ENG/中
美国
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerGPT
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
美國抗疫概念
1,480.06
+12.92
0.88%
漲家數:
10
跌家數:
10
平家數:
- -
市盈率:
- -
高:
1,487.39
開:
1,467.14
低:
1,462.61
收:
1,467.14
資料載入中...
總覽
新聞
吉利德科學(GILD.US)突破性小分子藥物獲歐盟批准 用於治療致命性肝病
智通财经
·
02-24
慢霧餘弦:確認CEX被盜事件黑客是朝鮮Lazarus Group,已揭露其攻擊方式
Blockbeats
·
02-23
輝瑞:退出基因療法賽道
谈思生物
·
02-23
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4568/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美國抗疫概念","latestPrice":1480.0557,"timestamp":1741381199999,"preClose":1467.1393,"halted":0,"volume":126573383,"delay":0,"changeRate":0.008804,"change":12.916382,"pbRate":4.037358,"amount":7265241469.443725,"amplitude":0.016884,"prevYearClose":1274.8187,"fiveDayClose":1463.5875,"twentyDayClose":1359.8558,"turnoverRate":0.008184,"marketCap":1220494102080,"floatMarketCap":1198623322288,"peRate":31.999995},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1487.3851,"amplitude":0.016884,"preClose":1467.1393,"low":1462.6143,"pbRate":"4.037358","latestPrice":1480.0557,"volume":126573383,"delay":0,"open":1467.1393,"prevYearClose":1274.8187,"prevWeekClose":1463.5875,"prevMonthClose":1463.5875,"prevQuarterClose":1274.8187,"fiveDayClose":1463.5875,"twentyDayClose":1359.8558,"sixtyDayClose":1300.6962,"secType":"PLATE","market":"US","turnoverRate":0.008184,"peRate":31.999995,"marketCap":1220494102080,"floatMarketCap":1198623322288,"timestamp":1741381199999,"nameCN":"美國抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":10,"down":10,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:16,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2513626227","title":"吉利德科學(GILD.US)突破性小分子藥物獲歐盟批准 用於治療致命性肝病","url":"https://stock-news.laohu8.com/highlight/detail?id=2513626227","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513626227?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 09:07","pubTimestamp":1740359262,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,吉利德科学公司日前宣布,欧盟委员会已有条件批准seladelpar上市,与熊去氧胆酸联用,治疗对UDCA单药应答不足的原发性胆汁性胆管炎患者。Seladelpar已于2024年8月获得美国FDA的加速批准,用于治疗PBC。Seladelpar曾获得FDA授予的突破性疗法认定以及针对PBC患者的孤儿药资格,以及欧洲药品管理局授予的PRIME资格。作为FDA加速批准的一部分,吉利德承诺进行一项名为AFFIRM的确认性长期结局研究,该研究已在代偿期肝硬化患者中启动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"吉利德科学(GILD.US)突破性小分子药物获欧盟批准 用于治疗致命性肝病","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1839511570.USD","BK4566","LU2087621335.USD","BK4588","LU1571399168.USD","IE00B19Z3B42.SGD","BK4139","BK4550","GILD","LU2468319806.SGD","LU0058720904.USD","IE0002270589.USD","LU0320765992.SGD","LU1430594728.SGD","LU0109394709.USD","BK4532","LU1066051498.USD","LU1585245621.USD","IE00B19Z3581.USD","LU0889565916.HKD","BK4585","BK4568","LU0234570918.USD","BK4583","IE00BKVL7J92.USD","LU1066053197.SGD","LU0289739699.SGD","IE00BSNM7G36.USD","LU2089984988.USD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","BK4578","IE00B7SZLL34.SGD"],"gpt_icon":0},{"id":"2513732140","title":"慢霧餘弦:確認CEX被盜事件黑客是朝鮮Lazarus Group,已揭露其攻擊方式","url":"https://stock-news.laohu8.com/highlight/detail?id=2513732140","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513732140?lang=zh_tw&edition=fundamental","pubTime":"2025-02-23 20:07","pubTimestamp":1740312420,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/282889","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["APT.USD.CC","APT","BK4568","BK4086","APT.USD.HKCC"],"gpt_icon":0},{"id":"2513791379","title":"輝瑞:退出基因療法賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2513791379","media":"谈思生物","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513791379?lang=zh_tw&edition=fundamental","pubTime":"2025-02-23 19:00","pubTimestamp":1740308434,"startTime":"0","endTime":"0","summary":"此前,辉瑞还终止了与Sangamo合作的A型血友病基因疗法,并撤回镰状细胞贫血疗法Oxbryta。关于此疗法的终止,辉瑞表示,主要原因是“患者和医生对血友病基因疗法兴趣有限”。其实,辉瑞在基因治疗领域早有动作。而且,辉瑞在2023年7月已将早期研发阶段的基因疗法以高达10亿美元的价格卖给了阿斯利康旗下的罕见病部门Alexion。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224104740a251503f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224104740a251503f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","SGXZ57979304.SGD","LU0321505868.SGD","LU0058720904.USD","BK4581","LU0225284248.USD","LU0234572021.USD","LU1023059063.AUD","LU0170899867.USD","LU1057294990.SGD","BK4568","LU1066053197.SGD","LU1894683348.USD","IE00BBT3K403.USD","LU0306807586.USD","SG9999002232.USD","LU1883839398.USD","IE00B19Z3B42.SGD","SG9999011175.SGD","IE00B19Z3581.USD","BK4599","SG9999002224.SGD","IE00BLSP4452.SGD","SG9999003800.SGD","BK4533","BK4550","LU1894683264.USD","IE0002270589.USD","LU0985481810.HKD","BK4588","BK4592","IE000M9KFDE8.USD","LU0225771236.USD","BK4007","PFE","SG9999001176.SGD","LU0306806265.USD","LU1066051498.USD","LU0289739699.SGD","LU0321505439.SGD","IE00BLSP4239.USD","SG9999013999.USD","SG9999001176.USD","LU0456855351.SGD","LU0122379950.USD","LU0868494617.USD","BK4585"],"gpt_icon":1}],"pageSize":16,"totalPage":10,"pageCount":10,"totalSize":147}]}}